Cogent Biosciences Cash Flow Statement (2017-2026) | COGT

Cash Flow Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-20.17M-26.82M-35.91M-74.62M-48.03M-39.98M-43.12M-47.30M-59.83M-58.99M-62.75M-64.73M-74.33M-59.96M-71.98M-76.05M-85.22M-110.06M-111.20M-101.72M
Share-based Compensation (Quarter)
3.46M-2.04M4.17M4.53M4.62M5.04M0.30M7.16M8.76M8.85M9.39M10.01M10.36M-29.76M10.01M9.72M10.60M1.10M16.91M17.11M
Deferred Taxes (Quarter)
Cash from Operations (Quarter)
-14.11M-20.78M-28.33M-26.46M-34.44M-29.41M-39.52M-32.07M-37.97M-44.07M-52.53M-42.70M-51.98M-60.58M-66.51M-54.54M-64.29M-79.11M-86.88M-77.27M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
1.18M1.04M0.74M-0.91M4.30M1.40M-2.58M6.20M2.60M0.95M-0.22M0.17M1.06M1.18M0.96M
Amortization of Deferred Charges (Quarter)
0.47M0.48M0.49M0.57M3.46M0.52M0.19M0.65M0.27M0.20M0.47M0.47M0.48M0.48M0.50M-0.43M0.30M1.66M0.28M0.63M
Depreciation & Amortization (CF) (Quarter)
0.05M0.07M0.07M0.10M0.26M0.38M0.53M0.56M0.58M0.63M0.60M0.61M0.62M0.68M0.64M0.66M0.64M0.66M0.63M0.74M
Change in Working Capital
Change in Receivables (Quarter)
Change in Account Payables (Quarter)
2.36M-0.87M0.53M-0.52M0.60M1.75M-1.67M2.99M2.71M0.79M4.91M-6.59M6.09M-3.05M2.14M2.47M-0.60M-6.53M4.24M-6.26M
Change in Accured Expenses (Quarter)
0.60M1.16M0.20M2.97M2.61M3.81M-2.56M1.85M6.25M2.63M-6.72M10.10M6.92M5.66M-8.66M5.68M4.57M9.10M-10.20M7.62M
Other Working Capital Changes (Quarter)
Investing Activities
Capital Expenditures (Quarter)
1.16M0.43M0.44M1.14M3.31M1.97M1.10M1.26M0.12M0.32M0.07M0.15M0.28M0.07M0.55M0.13M0.07M0.81M0.45M0.37M
Change in Acquisitions & Divestments (Quarter)
120.00M50.00M22.06M61.72M74.13M65.92M79.93M74.47M69.93M76.92M69.08M73.26M97.83M97.46M
Cash from Investing Activities (Quarter)
-1.16M-0.43M-0.44M-1.14M-151.54M28.41M59.88M-77.66M-90.54M10.49M1.04M-84.62M60.19M61.67M69.38M8.91M-155.05M-322.77M-36.46M14.28M
Financing Activities
Other financing activities (Quarter)
2.96M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
5.34M
Change in Capital Stock
Shares Issued (Quarter)
2.00M
Net Equity Issued and Repurchased (Quarter)
161.80M24.30M135.00M
Misc.
Cash from Financing Activities (Quarter)
2.96M
Change in Cash (Quarter)
-60.04M
Free Cash Flow (Quarter)
-77.64M
Net Cash Flow (Quarter)
-60.04M